Osteochondral Allograft is NOT Medically Necessary at This Time
The proposed osteochondral allograft to the lateral femoral condyle should be denied because three critical mandatory prerequisites have not been met: (1) no documentation of at least 6 weeks of supervised, in-person physical therapy, (2) severe meniscal deficiency requiring concurrent meniscal allograft transplantation, and (3) inadequate assessment of the opposing tibial articular surface. 1
Critical Missing Prerequisites
Supervised Physical Therapy Requirement
- The American Academy of Orthopaedic Surgeons mandates completion and documentation of at least 6 weeks of supervised, in-person physical therapy with objective documentation of compliance and failure to achieve adequate symptom relief before osteochondral allograft can be considered medically necessary 1
- The patient only reports "OTC medication, Home exercises for Range of Motion and Conditioning since 01/2025" - home exercises do not satisfy the requirement for supervised, in-person physical therapy 1
- This is a non-negotiable prerequisite that must be completed and documented with objective evidence of failure before proceeding 1
Meniscal Deficiency Must Be Addressed
- The MRI demonstrates "very little lateral meniscal tissue remaining" from the previous partial lateral meniscectomy, which represents severe meniscal deficiency 1
- The American Academy of Orthopaedic Surgeons requires either documentation of adequate remaining meniscal tissue OR planning concurrent meniscal allograft transplantation when meniscal deficiency exists 1
- An intact meniscus is essential for normal weight distribution within the joint - without adequate meniscal tissue, the osteochondral allograft is at high risk of failure due to abnormal load distribution 1
- Studies demonstrate that osteochondral allograft with concomitant meniscal allograft transplantation achieves 86% graft survivorship at 5 years when appropriately indicated 2
- The current surgical plan does not include meniscal allograft transplantation despite documented severe meniscal deficiency 1
Opposing Articular Surface Assessment
- The American Academy of Orthopaedic Surgeons requires definitive imaging assessment of the tibial plateau to confirm the opposing articular surface is free of significant disease or injury 1
- Bipolar lesions (both femoral and tibial involvement) are absolute contraindications for isolated osteochondral allograft 1
- The current documentation does not provide clear assessment of the tibial plateau cartilage status - the MRI report focuses on the femoral condyle and meniscus but lacks specific description of tibial articular cartilage integrity 1
- X-ray alone is insufficient; dedicated MRI assessment of the tibial plateau articular cartilage must be documented 1
Criteria That ARE Met
Lesion Characteristics
- The 2 x 4 cm (8 cm²) full-thickness cartilage defect on the lateral femoral condyle meets size criteria (≥2 cm diameter) for osteochondral allograft 1, 3
- The defect is appropriately sized for allograft rather than autograft - lesions 2-6 cm² are first-line indications for osteochondral allograft 1, 4
- Full-thickness (grade 3-4) cartilage loss on weight-bearing surface of the femoral condyle is documented 1
Patient Demographics and Knee Stability
- Age 34 years falls within the acceptable range (≤50 years) with best outcomes reported in patients younger than 30-40 years 1, 5
- Previous ACL reconstruction provides knee stability - physical examination confirms negative Lachman, anterior drawer, posterior drawer, and pivot shift tests with firm endpoints 1
- Knee alignment appears appropriate based on available imaging 1
Required Actions Before Approval
Mandatory Documentation Needed
Complete 6 weeks of supervised, in-person physical therapy with objective documentation including:
Address meniscal deficiency by either:
Obtain definitive tibial plateau assessment including:
Clinical Context and Prognosis
Expected Outcomes When Criteria Are Met
- Osteochondral allograft demonstrates 94% graft survival at 5 years and 84% at 10 years when appropriate patient selection criteria are followed 3
- Return to sport rates reach 88% with average time of 9.6 months when properly indicated 3
- Long-term studies show graft survival rates between 70-91% at greater than 10 years 6
Risk of Premature Surgery
- Proceeding without adequate meniscal tissue creates abnormal load distribution that significantly increases graft failure risk 1
- Skipping mandatory conservative treatment (supervised physical therapy) violates evidence-based treatment algorithms and may result in unnecessary surgery 1
- Unrecognized bipolar lesions are absolute contraindications and will lead to graft failure 1
Alternative Considerations
- The patient previously had cartilage biopsies obtained for possible MACI (matrix-induced autologous chondrocyte implantation), which remains an alternative for lesions of this size, though it requires two surgical procedures 3
- Best outcomes for osteochondral allograft are reported when treatment is performed within 12 months from symptom onset - this patient's symptoms date to 2018 ACL injury, though acute worsening may have occurred more recently 5
Recommendation: Non-certification with Letter of Intent requiring completion of supervised physical therapy, definitive tibial plateau assessment, and surgical plan revision to address meniscal deficiency before reconsideration.